tiprankstipranks
Rohto Pharmaceutical Co Ltd (JP:4527)
:4527
Japanese Market
4527
Rohto Pharmaceutical Co
RESEARCH TOOLSreports
Want to see JP:4527 full AI Analyst Report?

Rohto Pharmaceutical Co (4527) Income Statement

2 Followers

Rohto Pharmaceutical Co Income Statement

Last quarter (Q1 2026), Rohto Pharmaceutical Co's total revenue was ¥81.96B, an increase of 19.91% from the same quarter last year. In Q1, Rohto Pharmaceutical Co's net income was ¥11.77B. See Rohto Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 26Mar 25Mar 24Mar 23
Total Revenue
¥ 308.63B¥ 343.73B¥ 270.84B¥ 238.66B¥ 199.65B
Gross Profit
¥ 169.46B¥ 182.96B¥ 154.93B¥ 135.13B¥ 114.10B
Operating Expenses
¥ 131.00B¥ 142.25B¥ 114.77B¥ 101.59B¥ 86.24B
Depreciation and Amortization
¥ 13.14B¥ 17.38B¥ 8.69B¥ 7.80B¥ 7.69B
EBITDA
¥ 51.61B¥ 58.08B¥ 48.85B¥ 41.34B¥ 35.55B
Operating Income
¥ 38.47B¥ 40.71B¥ 40.17B¥ 33.54B¥ 27.86B
Other Income/Expenses
¥ 3.87B¥ 6.12B¥ 1.35B¥ 752.00M¥ 16.00M
Pretax Income
¥ 42.33B¥ 46.82B¥ 41.52B¥ 34.29B¥ 27.87B
Net Income
¥ 31.00B¥ 34.25B¥ 30.94B¥ 26.38B¥ 21.13B
Per Share Metrics
Basic EPS
¥ 136.11¥ 151.56¥ 135.60¥ 115.62¥ 92.61
Diluted EPS
¥ 135.44¥ 145.29¥ 135.21¥ 115.29¥ 92.34
Weighted Average Shares Outstanding
 227.80M 225.96M 228.14M 228.14M 228.14M
Weighted Average Shares Outstanding (Diluted)
 228.90M 235.46M 228.80M 228.80M 228.80M
Currency in JPY

Rohto Pharmaceutical Co Earnings and Revenue History